RxDoctor Payments Data

Paul Jeffords, MD

Orthopaedic Surgery of the Spine · Atlanta, GANPI 1033106570

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.7%), other and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Choice Spine, LLC at 40.5% of the total. Reporting peaked in 2023 at $312,623 and has fallen 67.8% since, to $100,548 in 2025.

$650,841in general payments, 2019–2025

Across 241 payments — averaging $2700.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Choice Spine, LLC$263K
  • Arteriocyte Medical Systems, Inc.$246K
  • Stryker$123K
  • Surgalign Spine Technologies, Inc.$9K
  • Globus Medical$5K
  • Mirus, LLC$2K
  • plus $2K from 12 others

What the payments were for

  • Royalty or licence$54,2148%
  • Consulting fees$251,83839%
  • Travel & lodging$90,89814%
  • Food & beverage$7,6801%
  • Education$1650%
  • Entertainment$480%
  • Other$245,99938%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$650,841 in reported general payments places this provider in the 85th percentile of 57 orthopaedic surgery of the spine providers in Georgia.

See all orthopaedic surgery of the spine providers in Georgia

Medicare billing

Part B allowed, 2024
$368,474
Medicare patients
327
Services billed
1,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen164$1,582
Celecoxib42$1,058
Gabapentin109$825
Pregabalin40$651
Tramadol Hcl151$465
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$415
Acetaminophen-CodeineAcetaminophen With Codeine32$278
Tizanidine Hcl35$138
Cyclobenzaprine Hcl13$103
Methylprednisolone16$81
Meloxicam41$80
Diazepam25$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →